Revive Therapeutics Ltd (RVVTF)

[Ecomike]

I agree with all of this but one part:

"Sell the wife’s car and buy a runner.

Binary event is imminent. Who wants to guess the outcome

I say the fda will approve the endpoint change but then ask for more trials.

Stock could gain on that outcome

The alternative is the deny to end point change but if that was the case they would have said so already imo "

This part is a no, not going to happen "but then ask for more trials."

They will tell RVVTF to unblind the rest of the data.

I hope MF is smart enough to find away to get the FDA to allow follow ups of all 710 people in the trial, to see if there is huge proof that Bucillamine made a huge difference in who did and did not get Long Haul Covid19 after the trial period.....

Then add that data to the final approval request.

Long haul Covid is going to be a massive 500 Billion dollar market, and many of the symptoms are just like RA, and Bucillamine has been used safely for 32 years for RA

IMO, the results will be very conclusive.

Then the question is will FDA approval for Covid19, also enable use for Long haul Covid19 with out further expense...